Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Republic of Korea | 9 | 2021 | 5858 | 0.25 | Why? |
| Arthralgia | 1 | 2021 | 173 | 0.20 | Why? |
| Nafcillin | 1 | 2018 | 4 | 0.19 | Why? |
| Gastrectomy | 1 | 2019 | 225 | 0.17 | Why? |
| Fungemia | 1 | 2018 | 86 | 0.17 | Why? |
| Histiocytic Necrotizing Lymphadenitis | 1 | 2017 | 23 | 0.17 | Why? |
| Delphi Technique | 1 | 2021 | 1257 | 0.16 | Why? |
| Interferon-gamma Release Tests | 1 | 2018 | 253 | 0.15 | Why? |
| Glycopeptides | 1 | 2018 | 199 | 0.15 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.15 | Why? |
| Myalgia | 1 | 2021 | 1015 | 0.15 | Why? |
| Fungi | 1 | 2018 | 471 | 0.14 | Why? |
| Candidemia | 1 | 2019 | 353 | 0.14 | Why? |
| Surgical Wound Infection | 1 | 2019 | 501 | 0.13 | Why? |
| Stomach Neoplasms | 1 | 2019 | 477 | 0.13 | Why? |
| Health Care Costs | 1 | 2019 | 1007 | 0.10 | Why? |
| Bacteremia | 2 | 2018 | 1372 | 0.10 | Why? |
| Resource Allocation | 1 | 2021 | 1771 | 0.10 | Why? |
| Antifungal Agents | 1 | 2019 | 1828 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.08 | Why? |
| Infant, Newborn | 3 | 2021 | 23105 | 0.07 | Why? |
| Infant | 3 | 2021 | 30274 | 0.06 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.06 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.06 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.06 | Why? |
| Joints | 1 | 2021 | 97 | 0.05 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.05 | Why? |
| Seoul | 1 | 2020 | 206 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Aged | 9 | 2021 | 215776 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.04 | Why? |
| Methicillin | 1 | 2018 | 73 | 0.04 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.04 | Why? |
| Adult | 9 | 2021 | 244371 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Operative Time | 1 | 2019 | 450 | 0.04 | Why? |
| Child | 3 | 2021 | 70012 | 0.04 | Why? |
| Lymph Node Excision | 1 | 2019 | 362 | 0.04 | Why? |
| Length of Stay | 3 | 2019 | 11042 | 0.04 | Why? |
| Female | 11 | 2021 | 380317 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Antibodies, Antinuclear | 1 | 2017 | 234 | 0.04 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 449 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| Humans | 16 | 2021 | 930598 | 0.03 | Why? |
| Virus Shedding | 2 | 2021 | 5834 | 0.03 | Why? |
| Drug Utilization | 1 | 2019 | 619 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Antipsychotic Agents | 1 | 2021 | 887 | 0.03 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.03 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| National Health Programs | 1 | 2019 | 807 | 0.03 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| C-Reactive Protein | 2 | 2018 | 7972 | 0.03 | Why? |
| Contact Tracing | 2 | 2021 | 8448 | 0.03 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Liver Function Tests | 1 | 2017 | 1325 | 0.03 | Why? |
| Antimicrobial Stewardship | 1 | 2018 | 931 | 0.03 | Why? |
| Program Evaluation | 1 | 2018 | 1929 | 0.02 | Why? |
| Patient Readmission | 1 | 2019 | 1543 | 0.02 | Why? |
| Retrospective Studies | 5 | 2019 | 105322 | 0.02 | Why? |
| L-Lactate Dehydrogenase | 1 | 2017 | 1995 | 0.02 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.02 | Why? |
| Decision Making | 1 | 2021 | 3132 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Comorbidity | 1 | 2019 | 34796 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.01 | Why? |
Seong's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(62)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_